Charles McWherter, President of R&D at CymaBay Therapeutics, Inc. (CBAY), sold 43,492 shares at $16.22 ($705K) on 2023-09-18, disclosed to the SEC on 2023-09-19.
Open-market sale of $705k CBAY by President of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.22 | 21,746 | $353K | 50.0% |
| 2 | $16.22 | 21,746 | $353K | 50.0% |
| Total | $16.22 avg | 43,492 | $705K | 100% |
| Filing → |
| CBAY | SELL | 2024-01-22 | $752K | — | Filing → |
| CBAY | SELL | 2023-12-18 | $487K | — | Filing → |
| CBAY | SELL | 2023-11-17 | $415K | — | Filing → |